HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bisucaberin, a new siderophore, sensitizing tumor cells to macrophage-mediated cytolysis. I. Taxonomy of the producing organism, isolation and biological properties.

Abstract
Alteromonas haloplanktis strain SB-1123 isolated from deep-sea mud produced a new siderophore, bisucaberin. Bisucaberin rendered tumor cells susceptible to cytolysis mediated by murine peritoneal macrophages which were elicited by Proteose peptone and not yet activated by lymphokine. Bisucaberin exerted its sensitizing activity by both the preincubation with tumor cells and the addition to co-culture of macrophages and tumor cells. The activity of bisucaberin was specifically inhibited by ferric ion. Bisucaberin showed direct cytostasis for tumor cells but did not cause cytolysis in the absence of macrophages. Cytostasis by bisucaberin was attributable to the specific inhibition of DNA synthesis in tumor cells.
AuthorsT Kameyama, A Takahashi, S Kurasawa, M Ishizuka, Y Okami, T Takeuchi, H Umezawa
JournalThe Journal of antibiotics (J Antibiot (Tokyo)) Vol. 40 Issue 12 Pg. 1664-70 (Dec 1987) ISSN: 0021-8820 [Print] England
PMID2962972 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • DNA, Neoplasm
  • Iron Chelating Agents
  • Peptides, Cyclic
  • Siderophores
  • bisucaberin
Topics
  • Antineoplastic Agents (isolation & purification, pharmacology)
  • Cell Survival (drug effects)
  • Cytotoxicity, Immunologic
  • DNA, Neoplasm (biosynthesis)
  • Fermentation
  • Gram-Negative Aerobic Bacteria (analysis)
  • Iron Chelating Agents (isolation & purification, pharmacology)
  • Macrophages (physiology)
  • Peptides, Cyclic (isolation & purification, pharmacology)
  • Seawater
  • Siderophores
  • Tumor Cells, Cultured (drug effects)
  • Water Microbiology

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: